Copyright & License | Emerging Pharmaceutical Sciences and Innovation

Emerging Pharmaceutical Sciences and Innovation (EPSI)

Emerging Pharmaceutical Sciences and Innovation is an international peer-reviewed academic platform dedicated to advancing cutting-edge research in pharmaceutical sciences, drug discovery, clinical therapeutics, and translational medicine. The journal serves as a multidisciplinary forum for scientists, researchers, healthcare professionals, and industry experts to share innovative findings that contribute to the development of safe, effective, and accessible medicines, published biannually online by Tecno Scientifica. Open Access — free for readers and authors, with no article processing charges. Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 3 weeks after submission. . About EPSI journal | All volumes & issues

Authors shall retain the copyright of their work and grant the Journal/Publisher rights for the first publication with the work concurrently licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, authors who submit their papers for publication by Emerging Pharmaceutical Sciences and Innovation agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse and transform the content.